-
Company Insights
Allianz – Digital Transformation Strategies
Allianz Digital Transformation Strategies Overview Allianz has been leveraging innovative technologies such as artificial intelligence, blockchain, cloud, big data, IoT, and cybersecurity to digitally transform its operations. The annual ICT spending of Allianz was estimated at $4.3 billion for 2023. A major share of this spending is earmarked for acquiring software, consulting, and hardware from vendors. Allianz provides global insurance and asset management services and offers life insurance and property and casualty insurance products under the Allianz and Euler Hermes...
-
Company Insights
Atos SE – Digital Transformation Strategies
Atos Digital Transformation Strategies Overview Atos SE (Atos) is tapping into the power of key disruptive technologies to offer new products/services and achieve operational efficiency. AI, big data, cloud, cybersecurity, and IoT are among the key technologies under focus for the company. The annual ICT spending of Atos is estimated at $725.5 million for 2023. A major share of this spending is earmarked for acquiring software, ICT services, and hardware from vendors. Atos is a French IT company. It offers...
-
Thematic Analysis
Drones in Aerospace and Defense – Thematic Intelligence
Explore the following trends and insights from our ‘Drones in Aerospace and Defense’ thematic intelligence report: Analyze the emerging technological trends shaping the use of drones in aerospace and defense theme and understand their broader impact on the defense market. Get an overview of the various drone programs and projects currently under development to understand the market better. The report will also help assess the diverse range of applications and use cases for this technology in both the civil and military...
-
Company Insights
Standard Chartered – Digital Transformation Strategies
Standard Chartered Digital Transformation Strategies Report Overview Standard Chartered has been focusing on cloud, automation, and open banking to digitally transform its operations. The annual ICT spending of Standard Chartered was estimated at $459.2 million for 2023. A major share of this spending is earmarked for acquiring software, network & communications, and hardware from vendors. Standard Chartered provides global financial services such as personal, wholesale, private, SME, and business banking solutions. Its portfolio of products includes savings and current accounts;...
-
Product Insights
Osteoporosis – Drugs In Development, 2023
Global Markets Direct’s, ‘Osteoporosis - Drugs In Development, 2023’, provides an overview of the Osteoporosis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Osteoporosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Systemic Sclerosis (Scleroderma) – Drugs In Development, 2023
Global Markets Direct’s, ‘Systemic Sclerosis (Scleroderma) - Drugs In Development, 2023’, provides an overview of the Systemic Sclerosis (Scleroderma) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Systemic Sclerosis (Scleroderma), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Sector Analysis
Treponema Pallidum Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
Treponema Pallidum Tests Market Report Overview The treponema pallidum tests market size was $540.5 million in 2023. Â Factors such as the increasing prevalence of syphilis, as well as growing public awareness will drive the market growth at a CAGR of more than 3% during 2023-2033. Treponema pallidum is the causative organism for Syphilis and cannot be cultivated in vitro, resulting in a need for specific IVD tests, rather than the more usual bacteriology testing. The identification of the Treponema pallidum...
-
Product Insights
Human Immunodeficiency Virus (HIV) Tests Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
HIV Tests Pipeline Market Report Overview Human Immunodeficiency Virus (HIV) tests refer to the antigens, antibodies, and nucleic acid reagent tests performed for the detection of HIV type I. The HIV Tests pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated...
-
Company Insights
AXA – Digital Transformation Strategies
AXA Enterprise Digital Transformation Strategies Report Overview AXA has been focusing on using artificial intelligence, cloud, big data, and blockchain to digitally transform its operations. The annual ICT spending of AXA was estimated at $2.2 billion for 2023. A major share of this spending is earmarked for acquiring software, consulting, and hardware from vendors. AXA is a global insurance company offering both life and non-life insurance products. It offers life insurance and savings products such as individual life insurance, group...
-
Sector Analysis
Human T-Lymphotropic Virus (HTLV) Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
Human T-Lymphotropic Virus (HTLV) Tests Market Report Overview The Human T-Lymphotropic Virus (HTLV) tests market size was valued at $83.6 million in 2023 and will grow at a CAGR of more than 4% from 2023 to 2033. HTLV tests are used for the detection of HTLV-1 and/or HTLV-II, retroviruses associated with, or suspected of causing aggressive adult T-cell lymphoma (ATL), and HTLV-I-associated myelopathy. Furthermore, it is also used for the detection of uveitis, Strongyloides stercoralis hyper-infection, neurological problems, chronic lung...